Lyra Therapeutics (LYRA) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-7.5
-5.04
-2.58
-0.12

Details

Expected EPS
-5.255
Actual EPS
-3.38
Surprise EPS
1.88
Surprise Percent
+35.68%

Description

Lyra Therapeutics (LYRA) has reported earnings of -3.38 per share for Q4 2025.

0 Comments

Share your thoughts